LigaChem Biosciences

141080.KQ

106.48 USD

-1.01

-0.94%

Overview

Last close

106.48 usd

Market cap

3.86B usd

52 week high

108.01 usd

52 week low

39.94 usd

Target price

116.63 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

37.1142

Price/Book Value

9.2912

Enterprise Value

3.57B usd

EV/Revenue

33.833

EV/EBITDA

158.0251

Key financials

Revenue TTM

105.41M usd

Gross Profit TTM

93.78M usd

EBITDA TTM

-5.25M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

502.02M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.